Regeneron high-dose Eylea gains FDA approval (NASDAQ:REGN)
Iryna Drozd The US FDA has approved Regeneron Pharmaceuticals' (NASDAQ:REGN) high-dose ("HD") version of its blockbuster therapy Eylea (aflibercept). The ...
Iryna Drozd The US FDA has approved Regeneron Pharmaceuticals' (NASDAQ:REGN) high-dose ("HD") version of its blockbuster therapy Eylea (aflibercept). The ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.